OncoK9 – Cancer Screening

Cancer is among the most common medical conditions that can affect companion animals. And while certain breeds may be more genetically predisposed to developing cancer, it’s a disease that can affect just about any pet at any time. The key to a positive outcome is early and accurate diagnosis. Safford Veterinary Services is pleased to offer OncoK9®, a multi-cancer early detection (MCED) test that works via a simple blood draw.

With human medicine, there are a number of methods used to screen for cancer before clinical signs emerge. This enables early detection, which can dramatically improve outcomes and long-term prognosis. Until recently, however, veterinary medicine lacked the ability to screen for and detect the signs of cancer early. OncoK9® liquid biopsy testing has changed this, enabling veterinarians to diagnose cancer early, when treatment can be much more effective.

A recent study conducted by PetDx^®, maker of OncoK9®, revealed that cancer was detected by the current standard of care in just 4% of dogs. Conversely, of the 350 dogs tested, the liquid biopsy screening test successfully detected cancer in about half of the dogs with preclinical disease. Furthermore, studies have also proven that OncoK9® is capable of detecting up to 30 different types of cancer, all with one simple blood draw.

A cancer diagnosis doesn’t have to be devastating – especially when that diagnosis can be reached before clinical signs begin to emerge. With OncoK9® liquid biopsy, we can stay a step ahead of cancer and put your beloved pet in a much better position to beat the disease once and for all! If you’d like more information or to schedule an OncoK9® test for your four-legged family member, contact Safford Veterinary Services today!